OncoImmunology
Volume 8, 2019 - Issue 6
Open access
6,096
Views
81
CrossRef citations to date
0
Altmetric
Review
Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?
Maria Eugenia DavolaDepartment of Pathology and Molecular Medicine, McMaster Immunology Research Centre, Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada
& Karen Louise MossmanDepartment of Pathology and Molecular Medicine, McMaster Immunology Research Centre, Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, CanadaCorrespondence[email protected]
http://orcid.org/0000-0002-1725-5873
Article: e1581528
|
Received 30 Jan 2019, Accepted 07 Mar 2019, Published online: 28 Mar 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.